Northern Trust’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $58.7K | Sell |
|
|||||
|
2023
Q2 | $37.6K | Hold |
|
|||||
|
2023
Q1 | $49.5K | Sell |
|
|||||
|
2022
Q4 | $61.9K | Hold |
|
|||||
|
2022
Q3 | $85K | Buy |
|
|||||
|
2022
Q2 | $131K | Sell |
|
|||||
|
2022
Q1 | $236K | Sell |
|
|||||
|
2021
Q4 | $347K | Sell |
|
|||||
|
2021
Q3 | $584K | Buy |
|
|||||
|
2021
Q2 | $639K | Buy |
|
|||||
|
2021
Q1 | $463K | Sell |
|
|||||
|
2020
Q4 | $412K | Sell |
|
|||||
|
2020
Q3 | $460K | Buy |
|
|||||
|
2020
Q2 | $451K | Sell |
|
|||||
|
2020
Q1 | $1.26M | Buy |
|
|||||
|
2019
Q4 | $1.91M | Buy |
|
|||||
|
2019
Q3 | $2.38M | Buy |
|
|||||
|
2019
Q2 | $1.35M | Buy |
|
|||||
|
2019
Q1 | $395K | Sell |
|
|||||
|
2018
Q4 | $258K | Sell |
|
|||||
|
2018
Q3 | $776K | Buy |
|
|||||
|
2018
Q2 | $612K | Sell |
|
|||||
|
2018
Q1 | $1.46M | Buy |
|
|||||
|
2017
Q4 | $1.79M | Buy |
|
|||||
|
2017
Q3 | $1.14M | Buy |
|
|||||
|
2017
Q2 | $2.31M | Buy |
|
|||||
|
2017
Q1 | $525K | Buy |
|
|||||
|
2016
Q4 | $378K | Buy |
|
|||||
|
2016
Q3 | $297K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $321K | Hold |
|
|||||
|
2015
Q4 | $342K | Buy |
|